RTRubin M. Tuder

Rubin M. Tuder

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rubin M. Tuder has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Jeong Hyun Yun

    Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, USA

    2 shared publications
  • Norbert F. Voelkel

    Department of Medicine Division of Pulmonary Sciences and Critical Care Medicine University of Colorado Health Sciences Center Denver Colorado 80262 USA

    2 shared publications
  • Brian B Graham

    1 shared publication
  • Brian B. Graham

    Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, Program in Translational Lung Research, and 2Department of Pathology, University of Colorado Denver, School of Medicine, Denver, Colorado

    1 shared publication
  • George R. Halley

    From the Department of Pathology (M.E.Y., G.R.H., R.M.T.), University of Colorado Health Sciences Center, Denver, Colo; Pulmonary Hypertension Center and Division of Respiratory and Critical Care Sciences (H.A.G., N.F.V., R.M.T.), Department of Medicine, University of Colorado Health Sciences Center, Denver, Colo

    1 shared publication
  • Gerald MC Mahon

    SUGEN Incorporated South San Francisco California 94080 USA

    1 shared publication

Latest Publications

    • 11 August 2009
      • Vol. 89  (30) , 2091-3

    [Pathogenesis of pulmonary hypertension].

    by Brian B Graham, Rubin M Tuder

  • Open Access

    Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse

    by Ricardo J. Giordano, Johanna Lahdenranta, Lijie Zhen, Ugonma Chukwueke, Irina Petrache, Robert R. Langley, Isaiah J. Fidler, Renata Pasqualini, Rubin M. Tuder, Wadih Arap


  • Open Access

    It takes two to tango: cigarette smoke partners with viruses to promote emphysema

    by Rubin M. Tuder, Jeong H. Yun

    Viruses constitute a constant and renewed threat to humans. Not only do viruses cause disease directly due to their tissue tropism and pathogenicity, but they have also been linked to autoimmunity. In their study in this issue of the JCI, Kang et al. show that exposure to cigarette smoke induces alterations in the innate immune response to viral infection and that these changes hasten alveolar destruction characteristic of emphysema in mice (see the related beginning on page 2771). This study builds on evidence that patients with chronic obstructive pulmonary disease have clinical exacerbations associated with viral or bacterial infections, which lead to worsened lung function and increased mortality. This novel paradigm may aid related genetic, biomarker, and therapeutic developments and provides important insights into the pathogenesis of emphysematous lung destruction.


  • Cigarette Smoke Triggers Code Red

    by Rubin M. Tuder, Jeong H. Yun, Brian B. Graham

    The article by Yao and coworkers in this issue (Am. J. Respir. Cell Mol. Biol. 2008;39:7–18) reveals that the cyclin-dependent kinase inhibitor p21CIP1/WAF1/SDI1 (designated hereafter as p21), which has been linked to cell cycle growth arrest due to stress or danger cell responses, may modulate alveolar inflammation and alveolar destruction, and thus enlightens our present understanding of how the lung senses injury due to cigarette smoke and integrates these responses with those that activate inflammatory pathways potentially harmful to the lung (1). Furthermore, the interplay of p21 and cellular processes involving cell senescence and the imbalance of cell proliferation/apoptosis may provide us with a more logical explanation of how p21, acting as a sensor of cellular stress, might have such potent and wide roles in lung responses triggered by cigarette smoke. Molecular switches, ontologically designed for the protection of the host, are now hijacked by injurious stresses (such as cigarette smoke), leading to organ damage.


  • Top Cited Papers
    Open Access

    Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

    by Laimute Taraseviciene‐Stewart, Yasunori Kasahara, Lori Alger, Peter Hirth, Gerald MC Mahon, Johannes Waltenberger, Norbert F. Voelkel, Rubin M. Tuder

    Our understanding of the pathobiology of severe pulmonary hypertension, usually a fatal disease, has been hampered by the lack of information of its natural history. We have demonstrated that, in human severe pulmonary hypertension, the precapillary pulmonary arteries show occlusion by proliferated endothelial cells. Vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR‐2) are involved in proper maintenance, differentiation, and function of endothelial cells. We demonstrate here that VEGFR‐2 blockade with SU5416 in combination with chronic hypobaric hypoxia causes severe pulmonary hypertension associated with precapillary arterial occlusion by proliferating endothelial cells. Prior to and concomitant with the development of severe pulmonary hypertension, lungs of chronically hypoxic SU5416‐treated rats show significant pulmonary endothelial cell death, as demonstrated by activated caspase 3 immunostaining and TUNEL. The broad caspase inhibitor Z‐Asp‐CH 2 DCB prevents the development of intravascular pulmonary endothelial cell growth and severe pulmonary hypertension caused by the combination of SU5416 and chronic hypoxia.—Taraseviciene‐Stewart, L., Kasahara, Y., Alger, L., Hirth, P., McMahon, G., Waltenberger, J., Voelkel, N. F., Tuder, R. M. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J. 15, 427‐438 (2001)


  • Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension

    by Michael E. Yeager, George R. Halley, Heiko A. Golpon, Norbert F. Voelkel, Rubin M. Tuder

    —Primary pulmonary hypertension (PPH) is a frequently fatal disease whose pathobiology is poorly understood. Monoclonal endothelial cell growth is present within plexiform lesions of patients with PPH but not secondary PH because of congenital heart malformations. We hypothesized that endothelial cells within PPH plexiform lesions harbor mutations permissive for clonal cell growth. We found that endothelial cells in PPH plexiform lesions demonstrated microsatellite instability within the human MutS Homolog 2 gene (10 of 20 lesions) and displayed microsatellite site mutations and reduced protein expression of transforming growth factor-β receptor type II (6 of 19 lesions) and Bax (4 of 19 lesions). These results suggest that, in PPH, proliferated endothelial cells have genetic alterations associated with microsatellite instability and concomitant perturbation of growth and apoptosis gene expression akin to neoplasia. The full text of this article is available at http://www.circresaha.org.